Literature DB >> 19913319

International Diabetes Federation: An update of the evidence concerning the prevention of type 2 diabetes.

R K Simmons1, N Unwin, S J Griffin.   

Abstract

This article aims to provide an updated summary of diabetes prevention efforts by reviewing relevant literature published between 2007 and 2009. These include results from the long-term follow-up of diabetes prevention trials and the roll-out of community-based interventions in "real world" settings. Some countries have begun to implement population-based strategies for chronic disease prevention, but investment in developing and evaluating population-level interventions remains inadequate. By focussing on the "small change" approach and involving a number of different agencies, it may be possible to shift the population distribution of risk factors for diabetes and cardiovascular disease in a favourable direction. The cost-effectiveness of primary prevention strategies for type 2 diabetes has not been universally demonstrated. Some of the uncertainties relating to screening for diabetes have now been resolved but longer-term data on hard cardiovascular outcomes are still needed. In summary, individual countries should aim to develop and evaluate cost-effective, setting-specific diabetes risk identification and prevention strategies based on available resources. These should be linked to initiatives aimed at reducing the burden of cardiovascular disease, and complemented with population-based strategies focusing on the control and reduction of behavioural and cardiovascular risk factors by targeting their key determinants. 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19913319     DOI: 10.1016/j.diabres.2009.10.003

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  19 in total

1.  Potential national and state medical care savings from primary disease prevention.

Authors:  Barbara A Ormond; Brenda C Spillman; Timothy A Waidmann; Kyle J Caswell; Bogdan Tereshchenko
Journal:  Am J Public Health       Date:  2010-11-18       Impact factor: 9.308

2.  SIRT1 interacts with metabolic transcriptional factors in the pancreas of insulin-resistant and calorie-restricted rats.

Authors:  Yong-Ru Chen; Yu-Lin Lai; Shao-da Lin; Xi-Tao Li; Yu-Cai Fu; Wen-Can Xu
Journal:  Mol Biol Rep       Date:  2013-01-06       Impact factor: 2.316

3.  Prevention of Diabetes Through the Lifestyle Intervention: Lessons Learned from the Diabetes Prevention Program and Outcomes Study and its Translation to Practice.

Authors:  Mary A Hoskin; George A Bray; Kathy Hattaway; Prajakta A Khare-Ranade; Jeremy Pomeroy; Linda N Semler; Valarie A Weinzierl; Judith Wylie-Rosett
Journal:  Curr Nutr Rep       Date:  2014-12-01

Review 4.  Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.

Authors:  Richard Kones
Journal:  Drug Des Devel Ther       Date:  2011-06-13       Impact factor: 4.162

5.  Evaluation of the modified FINDRISC to identify individuals at high risk for diabetes among middle-aged white and black ARIC study participants.

Authors:  Manjusha Kulkarni; Randi E Foraker; Ann M McNeill; Cynthia Girman; Sherita H Golden; Wayne D Rosamond; Bruce Duncan; Maria Ines Schmidt; Jaakko Tuomilehto
Journal:  Diabetes Obes Metab       Date:  2017-05-22       Impact factor: 6.577

6.  Implementation of a lifestyle intervention for type 2 diabetes prevention in Dutch primary care: opportunities for intervention delivery.

Authors:  Paulina W A Vermunt; Ivon E J Milder; Frits Wielaard; Caroline A Baan; Jos D M Schelfhout; Gert P Westert; Hans A M van Oers
Journal:  BMC Fam Pract       Date:  2012-08-08       Impact factor: 2.497

7.  Implementation salvage experiences from the Melbourne diabetes prevention study.

Authors:  James Dunbar; Andrea Hernan; Edward Janus; Nathalie Davis-Lameloise; Dino Asproloupos; Sharleen O'Reilly; Amy Timoshanko; Elizabeth Stewart; Catherine M Bennett; Greg Johnson; Rob Carter
Journal:  BMC Public Health       Date:  2012-09-19       Impact factor: 3.295

8.  Use of glucometer and fasting blood glucose as screening tools for diabetes mellitus type 2 and glycated haemoglobin as clinical reference in rural community primary care settings of a middle income country.

Authors:  Benja Muktabhant; Pattara Sanchaisuriya; Pongdech Sarakarn; Worawitaya Tawityanon; Mantana Trakulwong; Songsri Worawat; Frank P Schelp
Journal:  BMC Public Health       Date:  2012-05-14       Impact factor: 3.295

9.  Feasibility and effectiveness of the implementation of a primary prevention programme for type 2 diabetes in routine primary care practice: a phase IV cluster randomised clinical trial.

Authors:  Alvaro Sanchez; Carmen Silvestre; Regina Sauto; Catalina Martínez; Gonzalo Grandes
Journal:  BMC Fam Pract       Date:  2012-11-16       Impact factor: 2.497

10.  Motivational interviewing and problem solving treatment to reduce type 2 diabetes and cardiovascular disease risk in real life: a randomized controlled trial.

Authors:  Jeroen Lakerveld; Sandra D Bot; Mai J Chinapaw; Maurits W van Tulder; Piet J Kostense; Jacqueline M Dekker; Giel Nijpels
Journal:  Int J Behav Nutr Phys Act       Date:  2013-04-19       Impact factor: 6.457

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.